End in sight for Avecho as Phase III CBD trial moves into final stage by Adam Sheldon August 31, 2026August 31, 2026 Avecho Biotechnology has restarted recruitment for the final stage of its pivotal Phase III insomnia trial […]
Financial news in brief: Elixinol record quarter; Avecho identifies new trial sites by Steve Jones July 29, 2026July 30, 2026
Wait for CBD analysis was ‘torture’, says Avecho CEO as talks resume over licencing deals by Steve Jones July 9, 2026July 9, 2026
Avecho breathes ‘huge sigh of relief’ as early data points to successful CBD insomnia trial by Steve Jones June 24, 2026June 25, 2026
‘June will be huge’: Avecho boss bullish ahead of CBD trial analysis by Steve Jones March 26, 2026March 26, 2026
Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent by Adam Sheldon February 2, 2026June 8, 2026
News in brief: Avecho gains key patent allowances; Montu expands medical affairs team by Adam Sheldon December 9, 2025February 21, 2026
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
News in brief: Shahin becomes Vitura’s largest shareholder; Avecho progresses CBD insomnia trial; Epsilon reports improved cashflow; Zelira locks in R&D loan to advance trial by Adam Sheldon July 31, 2025July 31, 2025
Avecho advances sleep trial following deal with European pharma giant by cannabiz team May 20, 2025May 20, 2025
